Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220006608 220021256 1.77 72.3 Curative (C) 2014-09-08 2014-09-08 AML 19 TRIAL N N 220030648 AML19 TRIAL
220006609 220002543 1.78 85 Curative (C) 2017-09-23 2017-09-28 AML Relapsed FLA - Idarubicin N N 220030651 NOT MATCHED
220006610 220002543 1.63 128.4 Curative (C) null 2014-02-23 AML 19 TRIAL Y N 220030651 AML19 TRIAL
220006611 220002544 0.72 42 Curative (C) 2017-07-09 2017-10-13 AML MyeChild 01 B Cytarabine/Daunoxome + GO N N 220030653 NOT MATCHED
220006612 220002544 1.7 79.4 Curative (C) 2013-12-17 2013-12-25 ALL Ph+ve Dasatinib Continuation N N 220030653 NOT MATCHED
220006613 220002545 1.74 57 Curative (C) 2013-01-30 2013-01-30 AML 19 TRIAL Y N 220030661 AML19 TRIAL
220006614 220011467 1.65 105.5 Curative (C) 2016-07-15 2016-07-15 AML 19 TRIAL 01 N 220030664 AML19 TRIAL
220006615 220002546 1.68 17.4 Palliative (P) 2014-12-13 2014-12-13 AML MyeChild 01 B Cytarabine/Daunoxome 02 N 220030666 NOT MATCHED
220006616 220002546 1.73 71.2 Curative (C) 2016-11-01 2016-11-01 FLAG + Idarubicin 01 N 220030666 FLAG + IDARUBICIN
220006617 220002546 1.75 91 Curative (C) 2016-11-07 2016-11-08 AML 19 TRIAL Y N 220030666 AML19 TRIAL
220006618 220002546 1.59 101 Curative (C) 2014-07-01 2014-07-01 AML 19 TRIAL Y null 220030666 AML19 TRIAL
220006619 220002547 null 73.5 Curative (C) 2017-02-25 2017-02-28 FLAG + Idarubicin N N 220030679 FLAG + IDARUBICIN
220006620 220002547 1.63 94.3 Curative (C) 2016-05-12 2016-05-17 FLAG + Idarubicin N N 220030679 FLAG + IDARUBICIN
220006621 220002547 1.6 12.2 Curative (C) 2014-04-10 2014-04-11 Amsacrine + ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT) + BUSULFAN + CYTARABINE + FLUDARABINE N N 220030679 NOT MATCHED
220006622 220002547 0 70.9 null 2013-02-06 2013-02-08 Nilotinib N N 220030679 NILOTINIB
220006623 220002547 1.57 null Curative (C) 2013-04-08 2013-04-08 null N N 220030679 NOT MATCHED
220006624 220002547 1.61 null Disease modification (D) 2013-02-04 2013-02-07 Nilotinib N N 220030679 NILOTINIB
220006625 220002548 0 null Curative (C) 2013-05-24 2013-05-25 Nilotinib N N 220030693 NILOTINIB
220006626 220002548 0 101 Disease modification (D) 2017-03-13 2017-04-03 Nilotinib 99 N 220030693 NILOTINIB
220006627 220002549 1.87 68.4 Curative (C) 2014-09-13 2014-09-13 AML 19 TRIAL 01 N 220030695 AML19 TRIAL
220006628 220002549 null 52.1 Curative (C) 2016-02-06 2016-02-06 AML MyeChild N N 220030695 NOT MATCHED
220006629 220002549 0 null null 2015-11-19 2016-10-27 Nilotinib 02 null 220030695 NILOTINIB
220006630 220002549 1.7 84 Palliative (P) 2016-06-19 2016-06-19 FLAG + Idarubicin 02 N 220030695 FLAG + IDARUBICIN
220006631 220002549 1.68 0 Palliative (P) 2015-05-22 2015-05-22 Nilotinib N N 220030695 NILOTINIB
220006632 220002549 1.54 64.6 Curative (C) 2015-08-21 2015-08-22 FLAG + Idarubicin N N 220030695 FLAG + IDARUBICIN
220006633 220021737 null null Curative (C) 2015-10-01 2015-10-01 Nilotinib N N 220030705 NILOTINIB
220006634 220021737 1.8 81 Curative (C) 2013-03-17 2013-03-23 AML 19 TRIAL Y N 220030705 AML19 TRIAL
220006635 220002550 null 52.4 Curative (C) 2017-04-09 2017-04-12 AML 19 TRIAL 01 N 220030710 AML19 TRIAL
220006636 220011472 1.78 66.2 null 2013-07-19 2013-07-19 FLAG + Idarubicin null N 220030712 FLAG + IDARUBICIN
220006637 220011472 1.73 79.2 Curative (C) 2017-08-06 2017-08-06 AML 19 TRIAL Y N 220030712 AML19 TRIAL
220006638 220002551 0.91 89.35 Curative (C) 2015-11-30 2015-11-30 AML Interim Guidelines FLA -Ida 2 N 220030714 NOT MATCHED
220006639 220002551 1.56 95.5 Curative (C) 2015-11-07 2015-11-07 AML 19 TRIAL 01 N 220030714 AML19 TRIAL
220006640 220002552 1.88 62.2 Curative (C) 2015-08-14 2015-08-14 AML 19 TRIAL Y N 220030719 AML19 TRIAL
220006641 220002553 0 108.7 Adjuvant (A) 2015-11-01 2015-11-05 Nilotinib N N 220030721 NILOTINIB
220006642 220002554 1.56 null Curative (C) 2017-06-11 2017-06-14 AML 19 TRIAL 01 null 220030722 AML19 TRIAL
220006643 220002554 null 0 Curative (C) 2015-04-24 2015-04-29 Nilotinib N N 220030722 NILOTINIB
220006644 220002554 1.71 62.65 Curative (C) 2017-09-29 2017-10-02 AML 19 TRIAL 01 N 220030722 AML19 TRIAL
220006645 220002555 1.76 67.56 Curative (C) 2016-09-22 2016-09-23 AML 19 TRIAL 1 N 220030730 AML19 TRIAL
220006646 220002555 1.67 6 Curative (C) 2013-03-23 2013-03-26 FLAG + Idarubicin Y null 220030730 FLAG + IDARUBICIN
220006647 220002555 1.58 102 Curative (C) 2013-03-08 2013-03-08 AML 19 TRIAL Y N 220030730 AML19 TRIAL
220006648 220002556 0 null Curative (C) null 2013-04-30 Nilotinib N N 220030735 NILOTINIB
220006649 220002557 1.65 null Curative (C) 2016-06-26 2016-07-03 AML Interim Guidelines FLAG-Ida N null 220030736 FLAG + IDARUBICIN
220006650 220002557 null 88.9 null 2014-06-05 2014-06-17 Nilotinib 02 N 220030736 NILOTINIB
220006651 220002558 0 null Disease modification (D) 2016-01-19 2016-01-25 Nilotinib 2 N 220030738 NILOTINIB
220006652 220011477 1.78 82.8 Curative (C) 2016-11-24 2016-11-24 AML 19 TRIAL 1 N 220030739 AML19 TRIAL
220006653 220002559 1.73 48 Curative (C) 2014-05-21 2014-06-07 APML HR Ind ATO + ATRA N N 220030740 NOT MATCHED
220006654 220002559 null 63 Curative (C) 2014-06-10 2014-06-10 Nilotinib N N 220030740 NILOTINIB
220006655 220002560 1.74 74 Curative (C) 2013-08-03 2013-08-08 AML 19 TRIAL 1 N 220030748 AML19 TRIAL
220006656 220002560 null 98.2 Curative (C) 2017-10-16 2017-10-16 FLAG + Idarubicin 2 N 220030748 FLAG + IDARUBICIN
220006657 220002560 0 0 Disease modification (D) 2013-12-31 2014-01-02 Nilotinib N N 220030748 NILOTINIB